Extrovis Ag Is A Global Pharmaceutical Company Based In Switzerlandestablished In 2016 And Headquartered In Baarthe Company Operates As A Privately Held Corporation With Subsidiaries And Affiliates In Indiathe Euand The Usfocusing On Integrated Product Development And Manufacturing For The Pharmaceutical Market Extrovis Ag Produces Over Eight Active Pharmaceutical Ingredientsapis Including Dapsonecalcium Gluconateand Sugammadex Sodiumall Compliant With Dmf Cep Standardsthe Company Also Develops Finished Dosage Forms And Engages In Drug Development Across Various Therapeutic Areassuch As Oncology And Infectious Diseaseswith A Strong Emphasis On Regulatory Compliance And Qualityextrovis Ag Provides Market Insights And Technology Driven Solutions Tailored To The Needs Of Pharmaceutical Companiesthe Company Combines Its Swiss Headquarters With Research And Development And Production Facilities In Indiaemploying A Skilled Team Of Scientistsextrovis Ag Aims To Create Value Through Partnerships With Global Pharmaceutical Entitiesoffering Comprehensive Support From Api Synthesis To Commercialization
